Documente Academic
Documente Profesional
Documente Cultură
com
http://stabilitystudies.blogspot.com
Impurity
Any component of the new drug substance that is not the chemical entity defined as the new drug substance
http://stabilitystudies.blogspot.com
Types of impurities
Volatile
Unidentified
http://stabilitystudies.blogspot.com
Organic Impurities
Organic Impurities
Starting Materials
By-Products
Intermediates
Degradation Products
http://stabilitystudies.blogspot.com
Inorganic impurities
Inorganic Impurities
Inorganic salts
http://stabilitystudies.blogspot.com
API Synthesis
API Purification
Degradants
http://stabilitystudies.blogspot.com
Residual solvents
Solvents are inorganic or organic liquids used as vehicles for the preparation of solutions or suspensions in the synthesis of a new drug substance
http://stabilitystudies.blogspot.com
Solvent as an impurity
Solvents
http://stabilitystudies.blogspot.com
Drug substance
Drug Substance
Manufacturing
Starting Material
Reaction Byproducts
Unreacted Intermediates
Degradation Products
http://stabilitystudies.blogspot.com
Impurities in specification
Organic Impurities
Each specified identified impurity
Each specified unidentified impurity Any unspecified impurity with an acceptance
http://stabilitystudies.blogspot.com 10
Listing of impurities
% of Impurity > 1.0% < 1.0% Listing in specification 1.3 %( one digit after decimal place) 0.18% (Two digits after decimal Place)
http://stabilitystudies.blogspot.com
11
Others
Enantiomeric Impurity: A compound with the same molecular formula as the drug substance that differs in the spatial arrangement of atoms within the molecule and is a non-superimposable mirror image. Polymorphic Forms: Different crystalline forms of the same drug substance. These can include solvation or hydration products (also known as pseudo-polymorphs) and amorphous forms.
http://stabilitystudies.blogspot.com 12
Types
Potential Impurity: An impurity that theoretically can arise during manufacture or storage. It may or may not actually appear in the new drug substance. Actual Impurity: An impurity that is actually appear in the new drug substance.
http://stabilitystudies.blogspot.com
13
Qualification
Qualification: The process of acquiring and evaluating data that establishes the biological safety of an individual impurity or a given impurity profile at the level(s) specified. Qualification Threshold: A limit above (>) which an impurity should be qualified. Reporting Threshold: A limit above (>) which an impurity should be reported. Reporting threshold is the same as reporting level in Q2B.
http://stabilitystudies.blogspot.com 14
Thresholds
Max daily Dose Reporting threshold Identification Threshold Qualification Threshold
2 g / day
0.05%
> 2 g / day
0.03%
http://stabilitystudies.blogspot.com
15
Drug product
In the Drug product specification, only degradation products are to be incorporated as impurities. The degradation products include
or Reaction products of the drug substance with an excipient and/or Immediate container closure system
http://stabilitystudies.blogspot.com
16
The applicant should summarise the degradation products observed during manufacture and/or stability studies of the new drug product. Any degradation product observed in stability studies conducted at the recommended storage condition should be identified when present at a level greater than (>) the identification thresholds
http://stabilitystudies.blogspot.com 17
Analytical procedures
Validated analytical procedures should be used to analyze the impurities. As appropriate, this validation should include samples stored under relevant stress conditions: light, heat, humidity, acid/base hydrolysis, and oxidation. When an analytical procedure reveals the presence of other peaks in addition to those of the degradation products (e.g., the drug substance, impurities arising from the synthesis of the drug substance, excipients and impurities arising from the excipients), these peaks should be labeled in the chromatograms and their origin(s) discussed in the validation documentation.
http://stabilitystudies.blogspot.com
18
product Each specified unidentified degradation product Any unspecified degradation product with an acceptance criterion of not more than () the identification threshold Total Degradation products.
http://stabilitystudies.blogspot.com
19
Defs
Degradation Product: An impurity resulting from a chemical change in the drug substance brought about during manufacture and/or storage of the new drug product by the effect of, for example, light, temperature, pH, water, or by reaction with an excipient and/or the immediate container closure system. Degradation Profile: A description of the degradation products observed in the drug substance or drug product.
http://stabilitystudies.blogspot.com 20
Identification thresholds
Max Daily Dose *
< 1mg
Threshold
1.0% or 5 g TDI, whichever is lower 0.5% or 20 g TDI, whichever is lower 0.2 % or 2mg TDI, whichever is lower 0.10%
1mg-10 mg
> 10 mg
>2g
* Per Day
http://stabilitystudies.blogspot.com 21